Paper29445192
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
Saini M and 2 others. Cell Death Dis, 2018. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma. Papers, record 29445192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29445192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Membrane Proteins | Major topic |
| Proto-Oncogene Proteins c-met | Major topic |
| Cell Differentiation | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Child | |
| Humans | |
| Lymphatic Metastasis | |
| Muscle Development | |
| Organ Specificity | |
| Protein Binding | |
| Protein Stability | |
| RNA, Small Interfering | |
| Rhabdomyosarcoma, Alveolar | |
| Rhabdomyosarcoma, Embryonal | |
| Signal Transduction |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| IA/I/13/1/500872 | DBT-Wellcome Trust India Alliance | India | PubMed |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1717137 | Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. | Cancer Res | 1991 | https://conductscience.org/library/papers/1717137 | PubMed |
| 2 | 19536876 | Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. | Cancer | 2009 | https://conductscience.org/library/papers/19536876 | PubMed |
| 3 | 9472005 | Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. | J Cell Sci | 1998 | https://conductscience.org/library/papers/9472005 | PubMed |
| 4 | 9473336 | HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. | Dev Biol | 1998 | https://conductscience.org/library/papers/9473336 | PubMed |
| 5 | 23665679 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. | Oncogene | 2014 | https://conductscience.org/library/papers/23665679 | PubMed |
| 6 | 21575221 | Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. | J Transl Med | 2011 | https://conductscience.org/library/papers/21575221 | PubMed |
| 7 | 11478764 | ERK pathway positively regulates the expression of Sprouty genes. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11478764 | PubMed |
| 8 | 12783965 | Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. | J Clin Pathol | 2003 | https://conductscience.org/library/papers/12783965 | PubMed |
| 9 | 8622890 | Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. | Oncogene | 1996 | https://conductscience.org/library/papers/8622890 | PubMed |
| 10 | 6590967 | Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Nature | 1984 | https://conductscience.org/library/papers/6590967 | PubMed |
| 11 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 12 | 9398440 | Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. | Dev Biol | 1997 | https://conductscience.org/library/papers/9398440 | PubMed |
| 13 | 22672386 | Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22672386 | PubMed |
| 14 | 10805738 | p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10805738 | PubMed |
| 15 | 8633043 | Pax3 modulates expression of the c-Met receptor during limb muscle development. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8633043 | PubMed |
| 16 | 15122328 | Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. | Oncogene | 2004 | https://conductscience.org/library/papers/15122328 | PubMed |
| 17 | 14685170 | Met, metastasis, motility and more. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14685170 | PubMed |
| 18 | 11698404 | Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11698404 | PubMed |
| 19 | 9693375 | Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. | Mol Biol Cell | 1998 | https://conductscience.org/library/papers/9693375 | PubMed |
| 20 | 16861966 | An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. | Am J Surg Pathol | 2006 | https://conductscience.org/library/papers/16861966 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42140968 | Emergence of Sprouty role from the signaling interplay of DUSP1 and DUSP4 interactions in NSCLC pathogenesis. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/42140968 | PubMed |
| 41929490 | Intact lymph node homing and CD8+ T-cell priming abilities of Sprouty2-deficient dendritic cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929490 | PubMed |
| 41021275 | Functional Variant Discovery Identifies a Novel Genetic Link between SPRY2, Wood Smoke, and Asthma. | Am J Respir Cell Mol Biol | 2026 | https://conductscience.org/library/papers/41021275 | PubMed |
| 39970235 | Inhibiting mechanotransduction prevents scarring and yields regeneration in a large animal model. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/39970235 | PubMed |
| 38463968 | Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants. | bioRxiv | 2024 | https://conductscience.org/library/papers/38463968 | PubMed |
| 38177411 | The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma. | Oncogene | 2024 | https://conductscience.org/library/papers/38177411 | PubMed |
| 37097161 | Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis. | Cancer Med | 2023 | https://conductscience.org/library/papers/37097161 | PubMed |
| 37045830 | PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability. | Oncogenesis | 2023 | https://conductscience.org/library/papers/37045830 | PubMed |
| 36998041 | Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. | Diagn Pathol | 2023 | https://conductscience.org/library/papers/36998041 | PubMed |
| 36033507 | Non-coding RNA in rhabdomyosarcoma progression and metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36033507 | PubMed |
| 35008205 | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008205 | PubMed |
| 33919702 | Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33919702 | PubMed |
| 33568634 | Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33568634 | PubMed |
| 32517051 | The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32517051 | PubMed |
| 30874331 | The Sprouty/Spred family as tumor suppressors: Coming of age. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30874331 | PubMed |
| 30591655 | Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30591655 | PubMed |
| 29971532 | Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines. | J Cancer Res Clin Oncol | 2018 | https://conductscience.org/library/papers/29971532 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29445192
GET https://conductscience.org/api/papers/v1/29445192/references?page=2